0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Economic Impact of Adherence to Pain Treatment Guidelines in Chronic Pain Patients.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This research compared health care resource use (HCRU) and costs for pharmacotherapy prescribing that was adherent vs nonadherent to published pain management guidelines. Conditions included osteoarthritis (OA) and gout (GT) for nociceptive/inflammatory pain, painful diabetic peripheral neuropathy (pDPN) and post-herpetic neuralgia (PHN) for neuropathic pain, and fibromyalgia (FM) for sensory hypersensitivity pain.

          Related collections

          Author and article information

          Journal
          Pain Med
          Pain medicine (Malden, Mass.)
          Oxford University Press (OUP)
          1526-4637
          1526-2375
          Oct 01 2019
          : 20
          : 10
          Affiliations
          [1 ] IBM Watson Health, Bethesda, Maryland.
          [2 ] IBM Watson Health, Cambridge, Massachusetts, USA.
          [3 ] Pfizer Ltd, Tadworth, UK.
          [4 ] Pfizer Inc, Groton, Connecticut.
          [5 ] Self-employed, formerly Pfizer Inc, New York, New York.
          [6 ] Pfizer Inc, New York, New York, USA.
          Article
          5481414
          10.1093/pm/pnz085
          31034040
          adbe6874-c8c4-409d-95c9-47917050e5f0
          History

          Adherence,Health Care Resource Utilization,Health Care Costs,Drug Therapy,Chronic Pain,Treatment Guidelines

          Comments

          Comment on this article